Investor Centre


  • Analyst Reviews
    5-Mar-2018 – Bell Potter Review (440.4KB) Download
    28-Feb-2018 – Biotech Daily Crucible: Cyclopharm (0.00 B) Download
    29-Sep-2017 – Cyclopharm (CYC) First Patients In US Pivotal Study Enrolled. (Buy, PT$1.13) (439.69KB) Download
    30-Aug-2017 – Bell Potter Review (479.98KB) Download

Whether you are a shareholder or not, you can subscribe to receive all company announcements through our email alerts service.

To join email alerts, simply fill in your details using the form below and nominate which announcements you would like to receive.

Your privacy is important to us. If you no longer want to receive email alerts, use the unsubscribe link. If you are a shareholder and want to change your details or check your holdings, then use the share registry information on the contact us page.